LAX.SH
JUBILANT INGREVIA LIMITED·CHEMICALS 57.95·Chemicals & Petrochemicals Companies
Price
609.45
+2.09%52W Range
Market Cap
₹9,707.39 Cr
Traded: ₹12.79 Cr (0.13%) 0.0x
Free Float: ₹1,757.04 Cr (0.73% of FF traded)
Volume · 60D trend
2.12 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
RS Score
Create a free account to unlock your edge
Scanners, market pulse, FII/DII data, and TradingView charts — free forever
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | -- | +45.0% | -3.0% | -- | +11.0% | Stable |
| ROE | -- | +11.0% | +8.0% | -- | -- | Decelerating |
| Return | -- | +3.0% | +21.0% | -12.0% | -- | Stable |
| Profit | -- | +35.0% | -2.0% | -- | +15.0% | Stable |
Quarterly Results
Mar 2023
Dec 2022
Sep 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,300 | 1,179 | 1,051 | 1,121 | 1,038 | 1,051 | 1,057 | 1,045 | 1,024 | 1,074 | 966 | 1,020 | 1,075 | 1,145 | 1,158 | 1,304 |
| Expenses | 1,101 | 1,016 | 924 | 985 | 896 | 905 | 918 | 921 | 915 | 983 | 871 | 902 | 958 | 1,043 | 1,007 | 1,151 |
| Operating Profit | 199 | 163 | 126 | 135 | 142 | 147 | 138 | 124 | 110 | 91 | 96 | 118 | 117 | 102 | 151 | 153 |
| Other Income | 10 | 9 | -4 | 11 | 11 | 8 | 9 | 10 | 10 | 10 | 9 | 9 | 8 | 9 | 7 | 7 |
| Interest | 17 | 12 | 12 | 12 | 13 | 14 | 12 | 15 | 14 | 14 | 15 | 13 | 11 | 6 | 7 | 5 |
| Depreciation | 51 | 48 | 45 | 41 | 41 | 39 | 40 | 40 | 39 | 36 | 34 | 34 | 32 | 30 | 30 | 31 |
| Profit Before Tax | 141 | 112 | 65 | 93 | 100 | 102 | 96 | 80 | 66 | 51 | 55 | 80 | 81 | 76 | 122 | 124 |
| Tax % | 25.0% | 23.0% | 28.0% | 25.0% | 25.0% | 27.0% | 27.0% | 26.0% | 26.0% | 43.0% | 30.0% | 28.0% | 29.0% | 31.0% | 25.0% | 32.0% |
| Net Profit | 106 | 86 | 47 | 69 | 75 | 74 | 69 | 59 | 49 | 29 | 39 | 57 | 58 | 52 | 92 | 84 |
| Exceptional Items | -- | 0 | -13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -- |
| EPS (Rs) | 6.6 | 5.4 | 2.9 | 4.4 | 4.7 | 4.7 | 4.4 | 3.7 | 3.1 | 1.8 | 2.4 | 3.6 | 3.6 | 3.3 | 5.8 | 5.3 |
| Sales Growth (YoY) | 25.2% | 12.2% | -0.6% | 7.3% | 1.4% | -2.1% | 9.4% | 2.5% | -4.7% | -6.2% | -16.6% | -21.8% | -- | -- | -- | -- |
| Sales Growth (QoQ) | 10.3% | 12.2% | -6.2% | 8.0% | -1.2% | -0.6% | 1.1% | 2.0% | -4.7% | 11.2% | -5.3% | -5.1% | -6.1% | -1.1% | -11.2% | -- |
| OP Growth (YoY) | 40.1% | 10.9% | -8.7% | 8.9% | 29.1% | 61.5% | 43.8% | 5.1% | -6.0% | -10.8% | -36.4% | -22.9% | -- | -- | -- | -- |
| OP Growth (QoQ) | 22.1% | 29.4% | -6.7% | -4.9% | -3.4% | 6.5% | 11.3% | 12.7% | 20.9% | -5.2% | -18.6% | 0.9% | 14.7% | -32.5% | -1.3% | -- |
| Profit Growth (YoY) | -- | 17.0% | -19.0% | 18.0% | 54.0% | 153.0% | 80.0% | 3.0% | -15.0% | -44.0% | -58.0% | -32.0% | -27.0% | -24.0% | -29.0% | -24.0% |
| EPS Growth (YoY) | 41.0% | 16.8% | -32.6% | 17.8% | 53.9% | 152.7% | 80.2% | 2.5% | -15.5% | -43.9% | -57.9% | -31.8% | -- | -- | -- | -- |
| EPS Growth (QoQ) | 22.3% | 84.7% | -32.6% | -7.4% | 1.3% | 6.7% | 17.8% | 20.9% | 66.3% | -24.0% | -33.0% | -0.3% | 10.4% | -43.0% | 8.7% | -- |
| OP Margin | 15.3% | 13.8% | 12.0% | 12.0% | 13.7% | 14.0% | 13.1% | 11.9% | 10.7% | 8.5% | 9.9% | 11.6% | 10.9% | 8.9% | 13.0% | 11.7% |
| Net Margin | 8.2% | 7.3% | 4.5% | 6.2% | 7.2% | 7.0% | 6.5% | 5.7% | 4.8% | 2.7% | 4.0% | 5.6% | 5.4% | 4.5% | 7.9% | 6.4% |
| Material Cost % | -- | 52.0% | 53.0% | 54.0% | 50.0% | 51.0% | 51.0% | 49.0% | 52.0% | 55.0% | 53.0% | 50.0% | 50.0% | 57.0% | 53.0% | 55.0% |
| Employee Cost % | -- | 9.0% | 10.0% | 10.0% | 10.0% | 9.0% | 10.0% | 11.0% | 10.0% | 8.0% | 10.0% | 10.0% | 9.0% | 8.0% | 7.0% | 7.0% |
| P/S | 2.09 | 2.77 | 2.61 | 2.19 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 31.46 | 43.80 | 41.84 | 32.38 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 3.11 | 3.89 | 3.65 | 3.07 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Specimen of the intimation sent to shareholders
Company is organising a conference call on October 27, 2026, for discussion on the financial performance of the Company for the quarter and half year ended September 30, 2026
Jubilant Ingrevia Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2026 ,inter alia, to consider and approve Board meeting is scheduled ....
Incorporation of Wholly Owned Subsidiary
Commercial Paper proceeds utlisation certificate
Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018
Incorporation of Wholly Owned Subsidiary
Amendment in ESOP Scheme
Incorporation of Wholly Owned Subsidiary
Resignation of SMP
Intimation regarding closure of trading window
Scrutinizer Report along with Voting Results of the 7th AGM
Outcomes of AGM
Press Release
The Board approved to enter into binding term sheet with Zettaone Technologies India Private Limited (Zettaone) for acquisition of 40% strategic equity stake in Zettaone.
Annual Report of the Company for the Financial Year ended 2025-26
Business Responsibility and Sustainability Report of the Company for the Financial Year 2025-26
Notice of the 7th Annual General Meeting of the Company
Submission of unaudited Standalone and consolidated financial results for quarter ending June 30, 2026
Pursuant to Regulations 30 of the SEBI Listing Regulations, we wish to inform that audio recording of investors' Conference Call for un-audited financial results for the quarter ending June ....
Results of the Company for the quarter ended June 30, 2026
Grant of stock Options under Jubilant Ingrevia Employee Stock Option Scheme, 2021
Press Release and Presentation on the financial and operational performance of the Company for the quarter ended June 30, 2026
Press Release and Investor Presentation on the Financials and Operational Performance of the Company for the quarter ended June 30, 2026
Outcome of the Board Meeting held on July 22, 2026
We wish to inform you that the Company is organizing a conference call on July 23, 2026, at 05:00 pm (IST), for discussion on the financial performance of the Company for the quarter ended ....
Jubilant Ingrevia Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/07/2026 ,inter alia, to consider and approve Meeting of the Board of Directors ....
Certificate under Regulation 74(5) of the SEBI (Depositories Participants) Regulations, 2018
Intimation regarding closure of Trading Window
Schedule of Analysts/ Investors Meet
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 19, 2026 for HSB Trustee Company ....
Disclosure under Regulation 30 - Order in favour by Commissioner Central Goods and Service Tax (Appeals), Meerut
Transcript of the Investor''s Conference Call
Transcript of the Investor''s Conference Call
Intimation of Investor/Analyst Conference
Intimation of Investor/ Analyst Conference
Annual Secretarial Compliance Report for the Financial Year ended March 31, 2026
Newspaper Publication
Link of Audio recording of investors' conference call for audited financial results for the quarter and financial year ended March 31, 2026
Audited Financial Results for the Quarter and Year ended March 31, 2026
Intimation of Record date
Appointment of Cost Auditor
Press Release and Presentation on Financials
Press Release and Investor Presentation
Outcome of the Board Meeting held on May 26, 2026
Board approves Dividend
Assessment Order dated May 20, 2026 from the Assessment Unit, Income Tax Department for Assessment Year 2023-24
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Schedule for Investor Conference Call for Jubilant Ingrevia Limited -Audited Financial Results for the quarter and year ended March 31, 2026
Jubilant Ingrevia Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 ,inter alia, to consider and approve Intimation of Board Meeting ....
Credit Ratings
6Concalls
29Feb 2026
28 Feb 2026Oct 2025
31 Oct 2025Aug 2025
31 Aug 2025May 2025
31 May 2025Mar 2025
31 Mar 2025Jan 2025
31 Jan 2025Oct 2024
31 Oct 2024Oct 2024
31 Oct 2024Jul 2024
31 Jul 2024May 2024
31 May 2024Feb 2024
29 Feb 2024Nov 2023
30 Nov 2023Jul 2023
31 Jul 2023Jul 2023
31 Jul 2023May 2023
31 May 2023May 2023
31 May 2023Feb 2023
28 Feb 2023Feb 2023
28 Feb 2023Nov 2022
30 Nov 2022Aug 2022
31 Aug 2022May 2022
31 May 2022Mar 2022
31 Mar 2022Mar 2022
31 Mar 2022Feb 2022
28 Feb 2022Oct 2021
31 Oct 2021Sep 2021
30 Sept 2021Aug 2021
31 Aug 2021Jun 2021
30 Jun 2021May 2021
31 May 2021Held by ETFs
13 ETFs hold jublingrea · sorted by weight
Held by Mutual Funds
49 schemes hold jublingrea · sorted by weight